MX2018014955A - Vacunas atenuadas vivas del virus de la influenza equina. - Google Patents

Vacunas atenuadas vivas del virus de la influenza equina.

Info

Publication number
MX2018014955A
MX2018014955A MX2018014955A MX2018014955A MX2018014955A MX 2018014955 A MX2018014955 A MX 2018014955A MX 2018014955 A MX2018014955 A MX 2018014955A MX 2018014955 A MX2018014955 A MX 2018014955A MX 2018014955 A MX2018014955 A MX 2018014955A
Authority
MX
Mexico
Prior art keywords
influenza virus
equine influenza
attenuated vaccines
virus live
live
Prior art date
Application number
MX2018014955A
Other languages
English (en)
Inventor
Martinez-Sobrido Luis
Original Assignee
Univ Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rochester filed Critical Univ Rochester
Publication of MX2018014955A publication Critical patent/MX2018014955A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation
    • C12N2760/16162—Methods of inactivation or attenuation by genetic engineering

Abstract

La presente invención proporciona composiciones y métodos relacionados con las vacunas de la influenza atenuadas y vivas.
MX2018014955A 2016-06-03 2017-06-02 Vacunas atenuadas vivas del virus de la influenza equina. MX2018014955A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662345293P 2016-06-03 2016-06-03
PCT/US2017/035630 WO2017210528A1 (en) 2016-06-03 2017-06-02 Equine influenza virus live-attenuated vaccines

Publications (1)

Publication Number Publication Date
MX2018014955A true MX2018014955A (es) 2019-05-13

Family

ID=59351046

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018014955A MX2018014955A (es) 2016-06-03 2017-06-02 Vacunas atenuadas vivas del virus de la influenza equina.

Country Status (8)

Country Link
US (1) US10857224B2 (es)
EP (1) EP3463439B1 (es)
JP (1) JP2019520338A (es)
CN (1) CN109414488A (es)
BR (1) BR112018074910A2 (es)
CA (1) CA3026256A1 (es)
MX (1) MX2018014955A (es)
WO (1) WO2017210528A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3337504A1 (en) 2015-08-20 2018-06-27 University of Rochester Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus
US10857224B2 (en) * 2016-06-03 2020-12-08 University Of Rochester Equine influenza virus live attenuated vaccines
AR114410A1 (es) 2018-02-27 2020-09-02 Univ Rochester Vacuna multivalente contra influenza viva atenuada para prevenir y controlar el virus influenza equino (vie) en caballos
AR118202A1 (es) * 2019-02-27 2021-09-22 Univ Rochester Vacuna multivalente contra la influenza de virus vivos atenuados para la prevención y el control del virus de la influenza equina (eiv) en caballos

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166057A (en) 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems
US5854037A (en) 1989-08-28 1998-12-29 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand RNA virus expression systems and vaccines
DE69532369T3 (de) 1994-07-18 2010-11-04 Conzelmann, Karl-Klaus, Prof. Dr. Rekombinantes infektiöses nicht-in-Segmente-geteiltes, negativ-Strange-RNS-Virus
US7153510B1 (en) 1995-05-04 2006-12-26 Yale University Recombinant vesiculoviruses and their uses
EP0780475B2 (en) 1995-08-09 2006-07-19 SCHWEIZ. SERUM- & IMPFINSTITUT BERN Process for the production of infectious negative-strand RNA viruses
AU727923B2 (en) 1995-09-27 2001-01-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Production of infectious respiratory syncytial virus from cloned nucleotide sequences
KR100894670B1 (ko) 1996-07-15 2009-04-22 더 가번먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 에즈 레프리젠티드 바이 더 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈 클론닝된 뉴클레오타이드 서열로부터 약독화된 호흡기 세포융합 바이러스 백신의 생산
CA2265554A1 (en) 1996-09-27 1998-04-02 American Cyanamid Company 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales
AU7797798A (en) 1997-05-23 1998-12-11 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
WO1999002657A1 (en) 1997-07-11 1999-01-21 Yale University Rhabdoviruses with reengineered coats
JP2001517448A (ja) 1997-09-19 2001-10-09 アメリカン・サイアナミド・カンパニー 弱毒化呼吸合胞体ウイルス
US7425336B2 (en) 2005-08-25 2008-09-16 Mevial Limited Canine influenza vaccines
CN101309701A (zh) 2005-10-07 2008-11-19 辉瑞产品公司 治疗犬流感的疫苗和方法
US8475807B2 (en) * 2008-03-13 2013-07-02 University Of Maryland College Park Avian influenza virus live attenuated vaccine and uses thereof
WO2011044561A1 (en) * 2009-10-09 2011-04-14 The Research Foundation Of State University Of New York Attenuated influenza viruses and vaccines
US8457807B2 (en) * 2010-08-18 2013-06-04 International Business Machines Corporation Thermal relationships based workload planning
US20140302077A1 (en) 2011-09-02 2014-10-09 Westfaelische Wilhelms-Universitaet Munester Live attenuated influenza virus
CN105518129B (zh) * 2013-07-19 2020-04-28 罗切斯特大学 减毒流感疫苗和其用途
US10548966B2 (en) 2015-08-20 2020-02-04 University Of Rochester Single-cycle virus for the development of canine influenza vaccines
EP3337504A1 (en) 2015-08-20 2018-06-27 University of Rochester Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus
US10857224B2 (en) * 2016-06-03 2020-12-08 University Of Rochester Equine influenza virus live attenuated vaccines

Also Published As

Publication number Publication date
US10857224B2 (en) 2020-12-08
EP3463439A1 (en) 2019-04-10
BR112018074910A2 (pt) 2019-03-12
CA3026256A1 (en) 2017-12-07
EP3463439B1 (en) 2022-08-03
CN109414488A (zh) 2019-03-01
JP2019520338A (ja) 2019-07-18
WO2017210528A1 (en) 2017-12-07
US20190125860A1 (en) 2019-05-02

Similar Documents

Publication Publication Date Title
PH12016501873A1 (en) Anti-influenza b virus hemagglutinin antibodies and methods of use
PH12016502468B1 (en) Influenza virus vaccines and uses thereof
MX2021001053A (es) Vacunas contra virus de la influenza y sus usos.
MX2017001406A (es) Agentes a base de flagelina y usos de los mismos, incluyendo vacunación efectiva.
MX2018002106A (es) Vacunas terapeuticas contra el hpv18.
MY181175A (en) Therapeutic hpv16 vaccines
EA201692541A1 (ru) Вакцины против вируса гриппа и их применения
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
MX2021010060A (es) Produccion de virus en huevos aviares.
MY191539A (en) Streptococcal vaccine
PH12017500304A1 (en) Vaccine compositions against dengue virus diseases
EA201790517A1 (ru) Способы и композиции для индуцирования защитного иммунитета против филовирусной инфекции
MX2017016896A (es) Vacunas inactivadas contra la influenza canina, metodos para elaborarlas y sus usos.
MX2019005102A (es) Poxvirus quimericos sinteticos.
MX2018014955A (es) Vacunas atenuadas vivas del virus de la influenza equina.
HK1259146A1 (zh) 用於流感疫苗接種的方法和組合物
IN2014CH00840A (es)
SG11201704942QA (en) Dengue virus vaccine compositions and methods of use thereof
EA201691203A1 (ru) Твёрдые формы тенофовира
WO2015196180A3 (en) Influenza vaccines and methods of use thereof
MX2020008927A (es) Vacuna contra la influenza atenuada viva multivalente para la prevencion y el control del virus de la influenza equina (eiv) en caballos.
IL249704A0 (en) Influenza virus vaccines and their uses
IL249705A0 (en) Influenza virus vaccines and their uses